Roche heirs bid goodbye to ‘unsustainable’ philanthropy
Andre Hoffmann
Keystone / Georgios Kefalas
The heirs of Switzerland’s pharmaceutical company Roche are ending an era as philanthropic donors for major nature conservation projects, the NZZ am Sonntag reported.
This content was published on
2 minutes
Русский
ru
Концерн Roche прощается с «нерентабельной» филантропией
Their Mava Foundation, established 25 years ago, will shut down next year. “The traditional form of philanthropy has failed,” Roche Vice Chairman Andre Hoffmann told the German-language weekly in an interview published on Sunday.
Transferring money because you have a guilty conscience doesn’t do any good, the 63-year-old foundation president and economist explained.
“You may feel good about it yourself, but it doesn’t solve the problems,” he said. “Projects that exist only as long as we pay and stop when we withdraw are misguided.”
At last count, the Mava Foundation was involved in 180 projects with 120 partners. Many managed to continue and survive on their own, according to Hoffmann, spokesman for the Roche shareholder pool.
The foundation’s closure has been in the works for years.
Founded in 1994
The foundation, based in the town of Gland, canton Vaud, had been established in 1994. Launched by Hoffmann’s father, Luc, its original aim was to protect unique landscapes such as the Camargue.
Hoffmann told the newspaper he and his children would continue to support projects provided that they are based on a business model that ensured survival.
“The success of a project should not depend on the donor,” he stressed.
Hoffmann, who is involved in more than a dozen charitable activities, also called for greater accountability from companies when consumption of their products causes harm.
Food manufacturers, for example, should have to answer for health damage caused by excessive sugar content in their products, he said.
Greenwashing
He also criticised the way many companies still develop products without paying attention to their ecological footprint. It is only later that something is donated.
These companies, he argues, are guilty of greenwashing. “It’s not how you spend the money that matters, it’s how you do it,” he said.
Hoffmann believes the financial industry has the highest potential to make an impact because “it determines where the capital of pension funds and other investors goes”.
Related Stories
Popular Stories
More
How ‘nearshoring’ is driving Swiss companies to move to Mexico
Lindt & Sprüngli reportedly considering shifting Easter bunny production to US
This content was published on
Swiss chocolate manufacturer Lindt & Sprüngli could relocate the production of its gold-wrapped Easter bunnies to the US in order to circumvent the import tariffs imposed by the Trump administration.
Swiss petition launched against curbing 30km/h speed limit
This content was published on
The Traffic Club of Switzerland (TCS) has submitted a petition to the Federal Chancellery, challenging the 30km/h speed limit on local roads.
Swiss government backs abolishing imputed rental value
This content was published on
The abolition of the imputed rental value in federal tax is intended to reduce incentives for high private debt and simplify the tax system. On Friday, Finance Minister Karin Keller-Sutter spoke on behalf of the Federal Council in favour of Parliament's proposal.
This content was published on
After a strong start to the year, the Swiss economy has slowed considerably. In the second quarter, gross domestic product (GDP) rose by just 0.1 per cent on an adjusted basis compared to the previous quarter.
This content was published on
The Ticino cantonal criminal court in Lugano has found a priest guilty of multiple sexual assault and sexual offences with minors. The man was sentenced to a conditional 18-month prison term.
Swiss disappointed by failed plastics agreement in Geneva
This content was published on
Switzerland will not get its Geneva agreement against plastic pollution. Chief negotiator Felix Wertli spoke on Friday morning of his delegation's disappointment.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Eight Swiss in Bloomberg billionaire ‘rich list’
This content was published on
In the latest version of the Bloomberg Billionaires Index, eight Swiss or Swiss-resident names figure among the 500 richest people in the world.
Swiss pharma industry fights lower drug prices in the US
This content was published on
A proposed US law aims to lower prescription drug prices. But Big Pharma is pulling out all the stops to lobby against it.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.